REPORTS

Let’s Pullulate and Expand Your Business

G-Protein Coupled Receptor Market - Global Professional Analysis and Forecast to 2026

Oct 17, 2019  |  215 PAGES  |  REPORT CODE: CMM214278
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide G-Protein Coupled Receptor market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 12.2% during the forecast period.

This report presents the market size and development trends by detailing the G-Protein Coupled Receptor market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the G-Protein Coupled Receptor market will be shown in this report. In short, this report will comprehensively reveal the characteristics of G-Protein Coupled Receptor industry and will help you to build a panoramic view of the industrial development.

G-Protein Coupled Receptor Market, By Type:

  • Type 1

  • Type 2

  • Type 3

G-Protein Coupled Receptor Market, By Application:

  • End-Users 1

  • End-Users 2

  • End-Users 3

Some of the leading players are as follows:

  • Anchor Therapeutics (USA)

  • Arena Pharmaceuticals, Inc. (US)

  • Domain Therapeutics (France)

  • Trevena, Inc. (USA)

  • Dimerix Bioscience Pty Ltd (Australia)

  • DiscoveRx Corporation (USA)

  • 7TM Pharma A/S (Denmark)

  • Actelion Pharmaceuticals Ltd. (Switzerland)

  • Cara Therapeutics, Inc. (USA)

  • Euroscreen SA (Belgium)

  • Acadia Pharmaceuticals Inc., (USA)

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 G-Protein Coupled Receptor Market: Technology Type Analysis

  • 4.1 G-Protein Coupled Receptor Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 G-Protein Coupled Receptor Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 Type 1

    • 4.3.2 Type 2

    • 4.3.3 Type 3

5 G-Protein Coupled Receptor Market: Product Analysis

  • 5.1 G-Protein Coupled Receptor Product Market Share Analysis, 2018 & 2026

  • 5.2 G-Protein Coupled Receptor Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 G-Protein Coupled Receptor Market: Application Analysis

  • 6.1 G-Protein Coupled Receptor Application Market Share Analysis, 2018 & 2026

  • 6.2 G-Protein Coupled Receptor Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 End-User 1

    • 6.3.2 End-User 1

    • 6.3.3 End-User 3

7 G-Protein Coupled Receptor Market: Regional Analysis

  • 7.1 G-Protein Coupled Receptor Regional Market Share Analysis, 2018 & 2026

  • 7.2 G-Protein Coupled Receptor Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 Anchor Therapeutics (USA)

    • 9.1.1 Anchor Therapeutics (USA) Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 Arena Pharmaceuticals, Inc. (US)

    • 9.2.1 Arena Pharmaceuticals, Inc. (US) Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 Domain Therapeutics (France)

    • 9.3.1 Domain Therapeutics (France) Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 Trevena, Inc. (USA)

    • 9.4.1 Trevena, Inc. (USA) Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 Dimerix Bioscience Pty Ltd (Australia)

    • 9.5.1 Dimerix Bioscience Pty Ltd (Australia) Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 DiscoveRx Corporation (USA)

    • 9.6.1 DiscoveRx Corporation (USA) Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 7TM Pharma A/S (Denmark)

    • 9.7.1 7TM Pharma A/S (Denmark) Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 Actelion Pharmaceuticals Ltd. (Switzerland)

    • 9.8.1 Actelion Pharmaceuticals Ltd. (Switzerland) Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

  • 9.9 Cara Therapeutics, Inc. (USA)

    • 9.9.1 Cara Therapeutics, Inc. (USA) Company overview

    • 9.9.2 Financial performance

    • 9.9.3 Product benchmarking

    • 9.9.4 Strategic initiatives

    • 9.9.5 SWOT analysis

  • 9.10 Euroscreen SA (Belgium)

    • 9.10.1 Euroscreen SA (Belgium) Company overview

    • 9.10.2 Financial performance

    • 9.10.3 Product benchmarking

    • 9.10.4 Strategic initiatives

    • 9.10.5 SWOT analysis

  • 9.11 Acadia Pharmaceuticals Inc., (USA)

    • 9.11.1 Acadia Pharmaceuticals Inc., (USA) Company overview

    • 9.11.2 Financial performance

    • 9.11.3 Product benchmarking

    • 9.11.4 Strategic initiatives

    • 9.11.5 SWOT analysis

 

The List of Tables and Figures (Totals 103 Figures and 152 Tables)

  • Figure Type 1 G-Protein Coupled Receptor market, 2015 - 2026 (USD Million)

  • Figure Type 2 G-Protein Coupled Receptor market, 2015 - 2026 (USD Million)

  • Figure Type 3 G-Protein Coupled Receptor market, 2015 - 2026 (USD Million)

  • Figure End-Users 1 market, 2015 - 2026 (USD Million)

  • Figure End-Users 2 market, 2015 - 2026 (USD Million)

  • Figure End-Users 3 market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America G-Protein Coupled Receptor market, by country, 2015 - 2026 (USD Million)

  • Table North America G-Protein Coupled Receptor market, by type, 2015 - 2026 (USD Million)

  • Table North America G-Protein Coupled Receptor market, by product, 2015 - 2026 (USD Million)

  • Table North America G-Protein Coupled Receptor market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. G-Protein Coupled Receptor market, by type, 2015 - 2026 (USD Million)

  • Table U.S. G-Protein Coupled Receptor market, by product, 2015 - 2026 (USD Million)

  • Table U.S. G-Protein Coupled Receptor market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada G-Protein Coupled Receptor market, by type, 2015 - 2026 (USD Million)

  • Table Canada G-Protein Coupled Receptor market, by product, 2015 - 2026 (USD Million)

  • Table Canada G-Protein Coupled Receptor market, by application, 2015 - 2026 (USD Million)

  • Table Europe G-Protein Coupled Receptor market, by country, 2015 - 2026 (USD Million)

  • Table Europe G-Protein Coupled Receptor market, by type, 2015 - 2026 (USD Million)

  • Table Europe G-Protein Coupled Receptor market, by product, 2015 - 2026 (USD Million)

  • Table Europe G-Protein Coupled Receptor market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. G-Protein Coupled Receptor market, by type, 2015 - 2026 (USD Million)

  • Table U.K. G-Protein Coupled Receptor market, by product, 2015 - 2026 (USD Million)

  • Table U.K. G-Protein Coupled Receptor market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany G-Protein Coupled Receptor market, by type, 2015 - 2026 (USD Million)

  • Table Germany G-Protein Coupled Receptor market, by product, 2015 - 2026 (USD Million)

  • Table Germany G-Protein Coupled Receptor market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France G-Protein Coupled Receptor market, by type, 2015 - 2026 (USD Million)

  • Table France G-Protein Coupled Receptor market, by product, 2015 - 2026 (USD Million)

  • Table France G-Protein Coupled Receptor market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy G-Protein Coupled Receptor market, by type, 2015 - 2026 (USD Million)

  • Table Italy G-Protein Coupled Receptor market, by product, 2015 - 2026 (USD Million)

  • Table Italy G-Protein Coupled Receptor market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain G-Protein Coupled Receptor market, by type, 2015 - 2026 (USD Million)

  • Table Spain G-Protein Coupled Receptor market, by product, 2015 - 2026 (USD Million)

  • Table Spain G-Protein Coupled Receptor market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific G-Protein Coupled Receptor market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific G-Protein Coupled Receptor market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific G-Protein Coupled Receptor market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific G-Protein Coupled Receptor market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China G-Protein Coupled Receptor market, by type, 2015 - 2026 (USD Million)

  • Table China G-Protein Coupled Receptor market, by product, 2015 - 2026 (USD Million)

  • Table China G-Protein Coupled Receptor market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan G-Protein Coupled Receptor market, by type, 2015 - 2026 (USD Million)

  • Table Japan G-Protein Coupled Receptor market, by product, 2015 - 2026 (USD Million)

  • Table Japan G-Protein Coupled Receptor market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India G-Protein Coupled Receptor market, by type, 2015 - 2026 (USD Million)

  • Table India G-Protein Coupled Receptor market, by product, 2015 - 2026 (USD Million)

  • Table India G-Protein Coupled Receptor market, by application, 2015 - 2026 (USD Million)

  • Table Latin America G-Protein Coupled Receptor market, by country, 2015 - 2026 (USD Million)

  • Table Latin America G-Protein Coupled Receptor market, by type, 2015 - 2026 (USD Million)

  • Table Latin America G-Protein Coupled Receptor market, by product, 2015 - 2026 (USD Million)

  • Table Latin America G-Protein Coupled Receptor market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil G-Protein Coupled Receptor market, by type, 2015 - 2026 (USD Million)

  • Table Brazil G-Protein Coupled Receptor market, by product, 2015 - 2026 (USD Million)

  • Table Brazil G-Protein Coupled Receptor market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico G-Protein Coupled Receptor market, by type, 2015 - 2026 (USD Million)

  • Table Mexico G-Protein Coupled Receptor market, by product, 2015 - 2026 (USD Million)

  • Table Mexico G-Protein Coupled Receptor market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina G-Protein Coupled Receptor market, by type, 2015 - 2026 (USD Million)

  • Table Argentina G-Protein Coupled Receptor market, by product, 2015 - 2026 (USD Million)

  • Table Argentina G-Protein Coupled Receptor market, by application, 2015 - 2026 (USD Million)

  • Table MEA G-Protein Coupled Receptor market, by country, 2015 - 2026 (USD Million)

  • Table MEA G-Protein Coupled Receptor market, by type, 2015 - 2026 (USD Million)

  • Table MEA G-Protein Coupled Receptor market, by product, 2015 - 2026 (USD Million)

  • Table MEA G-Protein Coupled Receptor market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa G-Protein Coupled Receptor market, by type, 2015 - 2026 (USD Million)

  • Table South Africa G-Protein Coupled Receptor market, by product, 2015 - 2026 (USD Million)

  • Table South Africa G-Protein Coupled Receptor market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria G-Protein Coupled Receptor market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria G-Protein Coupled Receptor market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria G-Protein Coupled Receptor market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table Anchor Therapeutics (USA) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Arena Pharmaceuticals, Inc. (US) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Domain Therapeutics (France) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Trevena, Inc. (USA) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Dimerix Bioscience Pty Ltd (Australia) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table DiscoveRx Corporation (USA) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table 7TM Pharma A/S (Denmark) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Actelion Pharmaceuticals Ltd. (Switzerland) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Cara Therapeutics, Inc. (USA) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Euroscreen SA (Belgium) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Acadia Pharmaceuticals Inc., (USA) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$4840
$9680
BUY NOWClick MeBUY NOW
top